Effects of chronic and acute treatment of antipsychotic drugs on calmodulin release from rat striatal membranes
dc.contributor.author | Gnegy, Margaret E. | en_US |
dc.contributor.author | Lau, Y. S. | en_US |
dc.date.accessioned | 2006-04-07T17:26:42Z | |
dc.date.available | 2006-04-07T17:26:42Z | |
dc.date.issued | 1980-03 | en_US |
dc.identifier.citation | Gnegy, M. E., Lau, Y. S. (1980/03)."Effects of chronic and acute treatment of antipsychotic drugs on calmodulin release from rat striatal membranes." Neuropharmacology 19(3): 319-323. <http://hdl.handle.net/2027.42/23306> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T0C-479DJ99-12V/2/c24726fc2d54536f814b5afbfa785f44 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/23306 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6158710&dopt=citation | en_US |
dc.description.abstract | Chronic treatment of rats with the antipsychotic drugs haloperidol and (+)-butaclamol results in supersensitivity of striatal dopamine (DA) receptors. Striatal membranes of these animals have an increased content of an endogenous Ca -binding protein, calmodulin. Both endogenous and protein kinase-induced release of calmodulin from striatal membranes of the antipsychotic drug-treated animals were found substantially lower than that from saline or (-)-butaclamol-treated rats. Acute treatment with the antipsychotic drugs produced no alterations in calmodulin content or calmodulin release from the membranes. The impaired calmodulin release seen in the chronic antipsychotic drug-treated rats could be associated with the supersensitivity of DA receptors. | en_US |
dc.format.extent | 375761 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Effects of chronic and acute treatment of antipsychotic drugs on calmodulin release from rat striatal membranes | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology University of Michigan Medical School, Ann Arbor, Michigan 48109, USA | en_US |
dc.contributor.affiliationum | Department of Pharmacology University of Michigan Medical School, Ann Arbor, Michigan 48109, USA | en_US |
dc.identifier.pmid | 6158710 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/23306/1/0000244.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0028-3908(80)90156-2 | en_US |
dc.identifier.source | Neuropharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.